VitaNova Life Sciences (VNOV) Receivables - Net (2025 - 2026)

VitaNova Life Sciences (VNOV) posted Receivables - Net of $1.0 million for Q1 2026, up 13.8% on a QoQ basis from $882612.0 in Q4 2025.

VitaNova Life Sciences (VNOV) Receivables - Net (2025 - 2026) Analysis & Trends

VitaNova Life Sciences' Receivables - Net history runs 2 years deep, the most recent figure standing at $1.0 million for Q1 2026.

Quarterly Receivables - Net changed N/A year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $1.0 million (changed N/A YoY) and the FY2025 annual result came in at $1.3 million, changed N/A from the prior year.
Receivables - Net was $1.0 million for Q1 2026 at VitaNova Life Sciences, up from $882612.0 in the prior quarter.
Across five years, Receivables - Net topped out at $1.3 million in Q2 2025 and bottomed at $882612.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Mckesson	105.45 Bn	101.48 Bn	4.04 Bn
2	Cencora	60.61 Bn	58.43 Bn	3.59 Bn
3	Cardinal Health	53.92 Bn	49.99 Bn	2.50 Bn
4	Henry Schein	9.73 Bn	9.59 Bn	1.07 Bn
5	Akso Health	3.28 Bn	3.28 Bn	-
6	111	651.73 Mn	572.63 Mn	23.58 Mn
7	Accendra Health	246.88 Mn	-90.00 Mn	278.03 Mn
8	Edap Tms	228.64 Mn	213.64 Mn	8.15 Mn
9	VitaNova Life Sciences	11.51 Mn	11.01 Mn	316,343.00
10	Cosmos Health	9.58 Mn	7.42 Mn	1.38 Mn

Download Data